- Current report filing (8-K)
February 11 2009 - 10:39AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
________________
FORM 8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of
1934
Date of Report (Date of earliest event
reported):
February 11, 2009
AVIGEN, INC.
(Exact name of registrant as specified in charter)
|
Delaware
|
000-28272
|
13-3647113
|
|
(State or
other jurisdiction of
|
(Commission
File Number)
|
(I.R.S.
Employer Identification
|
|
incorporation)
|
|
No.)
|
1301 Harbor Bay Parkway
Alameda,
California 94502
(Address of
principal executive offices and zip code)
Registrant’s telephone number, including
area code:
(510) 748-7150
______________________________
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
o
Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 2.02. Results of Operations and
Financial Condition.
On
February 11, 2009
, Avigen, Inc. issued a
press release announcing its financial results for the
year ended December 31, 2008
. A copy of
the press release is attached as Exhibit 99.1 to this current report and is
incorporated herein by reference.
The information in this Section 2.02
and in the press release attached as Exhibit 99.1 to this current report, shall
not be deemed to be “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the liabilities of
that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as
amended. The information contained in this Section 2.02 and in the accompanying
exhibit shall not be incorporated by reference into any filing with the U.S.
Securities and Exchange Commission made by Avigen, Inc., whether made before or
after the date hereof, regardless of any general incorporation language in such
filing.
Item 9.01 Financial Statements and
Exhibits.
|
Exhibit
|
|
|
|
Number
|
|
Description
|
|
99.1
|
|
Press Release, dated
February 11, 2009
,
announcing Avigen’s financial results for the year ended December 31,
2008
.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, hereunto
duly authorized.
|
|
AVIGEN, INC.
|
|
|
|
|
|
Dated:
February 11,
2009
|
By:
|
|
/s/
ANDREW A. SAUTER
|
|
|
|
|
|
|
Andrew
A. Sauter
|
|
|
|
|
|
Chief
Financial Officer
|
INDEX
TO
EXHIBITS
|
Exhibit
|
|
|
|
Number
|
|
Description
|
|
99.1
|
|
Press Release, dated February 11,
2009, announcing Avigen’s financial results for the year ended December
31, 2008
.
|
|
|
|
|
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Jul 2023 to Jul 2024
